| Year |
Citation |
Score |
| 2021 |
Chuang SJ, Johanns M, Pyr Dit Ruys S, Steinberg GR, Kemp B, Viollet B, Rider MH. AMPK activation by SC4 inhibits noradrenaline-induced lipolysis and insulin-stimulated lipogenesis in white adipose tissue. The Biochemical Journal. PMID 34668531 DOI: 10.1042/BCJ20210411 |
0.403 |
|
| 2021 |
Olivier S, Pochard C, Diounou H, Castillo V, Divoux J, Alcantara J, Leclerc J, Guilmeau S, Huet C, Charifi W, Varin TV, Daniel N, Foretz M, Neunlist M, Salomon BL, ... ... Viollet B, et al. Deletion of intestinal epithelial AMP-activated protein kinase alters distal colon permeability but not glucose homeostasis. Molecular Metabolism. 101183. PMID 33548500 DOI: 10.1016/j.molmet.2021.101183 |
0.306 |
|
| 2020 |
Schmoll D, Ziegler N, Viollet B, Foretz M, Even PC, Azzout-Marniche D, Nygaard Madsen A, Illemann M, Mandrup K, Feigh M, Czech J, Glombik H, Olsen JA, Hennerici W, Steinmeyer K, et al. Activation of Adenosine Monophosphate-Activated Protein Kinase Reduces the Onset of Diet-Induced Hepatocellular Carcinoma in Mice. Hepatology Communications. 4: 1056-1072. PMID 32626837 DOI: 10.1002/hep4.1508 |
0.312 |
|
| 2020 |
Gutiérrez-Salmerón M, García-Martínez JM, Martínez-Useros J, Fernández-Aceñero MJ, Viollet B, Olivier S, Chauhan J, Lucena SR, De la Vieja A, Goding CR, Chocarro-Calvo A, García-Jiménez C. Paradoxical activation of AMPK by glucose drives selective EP300 activity in colorectal cancer. Plos Biology. 18: e3000732. PMID 32603375 DOI: 10.1371/journal.pbio.3000732 |
0.32 |
|
| 2020 |
Lantier L, Williams AS, Williams IM, Guerin A, Bracy DP, Goelzer M, Foretz M, Viollet B, Hughey CC, Wasserman DH. Reciprocity Between Skeletal Muscle AMPK Deletion and Insulin Action in Diet-Induced Obese Mice. Diabetes. PMID 32439824 DOI: 10.2337/db19-1074 |
0.415 |
|
| 2020 |
Moonira T, Chachra SS, Ford BE, Marin S, Alshawi A, Adam-Primus NS, Arden C, Al-Oanzi ZH, Foretz M, Viollet B, Cascante M, Agius L. Metformin lowers glucose 6-phosphate in hepatocytes by activation of glycolysis downstream of glucose phosphorylation. The Journal of Biological Chemistry. PMID 31974165 DOI: 10.1074/Jbc.Ra120.012533 |
0.329 |
|
| 2019 |
Ducommun S, Deak M, Zeigerer A, Göransson O, Seitz S, Collodet C, Madsen AB, Jensen TE, Viollet B, Foretz M, Gut P, Sumpton D, Sakamoto K. Chemical genetic screen identifies Gapex-5/GAPVD1 and STBD1 as novel AMPK substrates. Cellular Signalling. 57: 45-57. PMID 30772465 DOI: 10.1016/j.cellsig.2019.02.001 |
0.305 |
|
| 2017 |
Lopez-Mejia IC, Lagarrigue S, Giralt A, Martinez-Carreres L, Zanou N, Denechaud PD, Castillo-Armengol J, Chavey C, Orpinell M, Delacuisine B, Nasrallah A, Collodet C, Zhang L, Viollet B, Hardie DG, et al. CDK4 Phosphorylates AMPKα2 to Inhibit Its Activity and Repress Fatty Acid Oxidation. Molecular Cell. 68: 336-349.e6. PMID 29053957 DOI: 10.1016/j.molcel.2017.09.034 |
0.343 |
|
| 2017 |
Hughey CC, James FD, Bracy DP, Donahue EP, Young JD, Viollet B, Foretz M, Wasserman DH. Loss of hepatic AMP-activated protein kinase impedes the rate of glycogenolysis but not gluconeogenic fluxes in exercising mice. The Journal of Biological Chemistry. PMID 29038293 DOI: 10.1074/Jbc.M117.811547 |
0.336 |
|
| 2017 |
Thomas A, Belaidi E, Moulin S, Horman S, van der Zon GC, Viollet B, Levy P, Bertrand L, Pepin JL, Godin-Ribuot D, Guigas B. Chronic Intermittent Hypoxia Impairs Insulin Sensitivity but Improves Whole-Body Glucose Tolerance by Activating Skeletal Muscle AMPK. Diabetes. PMID 28882901 DOI: 10.2337/db17-0186 |
0.405 |
|
| 2017 |
Cokorinos EC, Delmore J, Reyes AR, Albuquerque B, Kjøbsted R, Jørgensen NO, Tran JL, Jatkar A, Cialdea K, Esquejo RM, Meissen J, Calabrese MF, Cordes J, Moccia R, Tess D, ... ... Viollet B, et al. Activation of Skeletal Muscle AMPK Promotes Glucose Disposal and Glucose Lowering in Non-human Primates and Mice. Cell Metabolism. 25: 1147-1159.e10. PMID 28467931 DOI: 10.1016/J.Cmet.2017.04.010 |
0.414 |
|
| 2017 |
Hasenour CM, Ridley DE, James FD, Hughey CC, Donahue EP, Viollet B, Foretz M, Young JD, Wasserman DH. Liver AMP-Activated Protein Kinase Is Unnecessary for Gluconeogenesis but Protects Energy State during Nutrient Deprivation. Plos One. 12: e0170382. PMID 28107516 DOI: 10.1371/journal.pone.0170382 |
0.333 |
|
| 2016 |
Sayers SR, Reimann F, Gribble FM, Parker H, Zac-Varghese S, Bloom SR, Foretz M, Viollet B, Rutter GA. Proglucagon Promoter Cre-Mediated AMPK Deletion in Mice Increases Circulating GLP-1 Levels and Oral Glucose Tolerance. Plos One. 11: e0149549. PMID 27010458 DOI: 10.1371/Journal.Pone.0149549 |
0.309 |
|
| 2015 |
Sun G, da Silva Xavier G, Gorman T, Priest C, Solomou A, Hodson DJ, Foretz M, Viollet B, Herrera PL, Parker H, Reimann F, Gribble FM, Migrenne S, Magnan C, Marley A, et al. LKB1 and AMPKα1 are required in pancreatic alpha cells for the normal regulation of glucagon secretion and responses to hypoglycemia. Molecular Metabolism. 4: 277-86. PMID 25830091 DOI: 10.1016/J.Molmet.2015.01.006 |
0.331 |
|
| 2015 |
Fentz J, Kjøbsted R, Birk JB, Jordy AB, Jeppesen J, Thorsen K, Schjerling P, Kiens B, Jessen N, Viollet B, Wojtaszewski JFP. AMPKα is critical for enhancing skeletal muscle fatty acid utilization during in vivo exercise in mice Faseb Journal. 29: 1725-1738. PMID 25609422 DOI: 10.1096/fj.14-266650 |
0.326 |
|
| 2014 |
Patel K, Foretz M, Marion A, Campbell DG, Gourlay R, Boudaba N, Tournier E, Titchenell P, Peggie M, Deak M, Wan M, Kaestner KH, Göransson O, Viollet B, Gray NS, et al. The LKB1-salt-inducible kinase pathway functions as a key gluconeogenic suppressor in the liver. Nature Communications. 5: 4535. PMID 25088745 DOI: 10.1038/Ncomms5535 |
0.377 |
|
| 2014 |
Lai YC, Kviklyte S, Vertommen D, Lantier L, Foretz M, Viollet B, Hallén S, Rider MH. A small-molecule benzimidazole derivative that potently activates AMPK to increase glucose transport in skeletal muscle: comparison with effects of contraction and other AMPK activators. The Biochemical Journal. 460: 363-75. PMID 24665903 DOI: 10.1042/BJ20131673 |
0.383 |
|
| 2014 |
Lantier L, Fentz J, Mounier R, Leclerc J, Treebak JT, Pehmøller C, Sanz N, Sakakibara I, Saint-Amand E, Rimbaud S, Maire P, Marette A, Ventura-Clapier R, Ferry A, Wojtaszewski JF, ... ... Viollet B, et al. AMPK controls exercise endurance, mitochondrial oxidative capacity, and skeletal muscle integrity. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 28: 3211-24. PMID 24652947 DOI: 10.1096/fj.14-250449 |
0.54 |
|
| 2014 |
Hasenour CM, Ridley DE, Hughey CC, James FD, Donahue EP, Shearer J, Viollet B, Foretz M, Wasserman DH. 5-Aminoimidazole-4-carboxamide-1-β-D-ribofuranoside (AICAR) effect on glucose production, but not energy metabolism, is independent of hepatic AMPK in vivo. The Journal of Biological Chemistry. 289: 5950-9. PMID 24403081 DOI: 10.1074/jbc.M113.528232 |
0.397 |
|
| 2013 |
Jenkins Y, Sun TQ, Markovtsov V, Foretz M, Li W, Nguyen H, Li Y, Pan A, Uy G, Gross L, Baltgalvis K, Yung SL, Gururaja T, Kinoshita T, Owyang A, ... ... Viollet B, et al. AMPK activation through mitochondrial regulation results in increased substrate oxidation and improved metabolic parameters in models of diabetes. Plos One. 8: e81870. PMID 24339975 DOI: 10.1371/Journal.Pone.0081870 |
0.342 |
|
| 2013 |
Liu Y, Lai YC, Hill EV, Tyteca D, Carpentier S, Ingvaldsen A, Vertommen D, Lantier L, Foretz M, Dequiedt F, Courtoy PJ, Erneux C, Viollet B, Shepherd PR, Tavaré JM, et al. Phosphatidylinositol 3-phosphate 5-kinase (PIKfyve) is an AMPK target participating in contraction-stimulated glucose uptake in skeletal muscle. The Biochemical Journal. 455: 195-206. PMID 23905686 DOI: 10.1042/BJ20130644 |
0.386 |
|
| 2013 |
Miller RA, Chu Q, Xie J, Foretz M, Viollet B, Birnbaum MJ. Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP. Nature. 494: 256-60. PMID 23292513 DOI: 10.1038/Nature11808 |
0.373 |
|
| 2013 |
Meijer RI, Bakker W, Alta CL, Sipkema P, Yudkin JS, Viollet B, Richter EA, Smulders YM, van Hinsbergh VW, Serné EH, Eringa EC. Perivascular adipose tissue control of insulin-induced vasoreactivity in muscle is impaired in db/db mice. Diabetes. 62: 590-8. PMID 23048187 DOI: 10.2337/db11-1603 |
0.355 |
|
| 2012 |
Lee JH, Budanov AV, Talukdar S, Park EJ, Park HL, Park HW, Bandyopadhyay G, Li N, Aghajan M, Jang I, Wolfe AM, Perkins GA, Ellisman MH, Bier E, Scadeng M, ... ... Viollet B, et al. Maintenance of metabolic homeostasis by Sestrin2 and Sestrin3. Cell Metabolism. 16: 311-21. PMID 22958918 DOI: 10.1016/J.Cmet.2012.08.004 |
0.36 |
|
| 2012 |
Zhang W, Zhang X, Wang H, Guo X, Li H, Wang Y, Xu X, Tan L, Mashek MT, Zhang C, Chen Y, Mashek DG, Foretz M, Zhu C, Zhou H, ... ... Viollet B, et al. AMP-activated protein kinase α1 protects against diet-induced insulin resistance and obesity. Diabetes. 61: 3114-25. PMID 22829451 DOI: 10.2337/Db11-1373 |
0.348 |
|
| 2012 |
Wu Y, Zhang C, Dong Y, Wang S, Song P, Viollet B, Zou MH. Activation of the AMP-activated protein kinase by eicosapentaenoic acid (EPA, 20:5 n-3) improves endothelial function in vivo. Plos One. 7: e35508. PMID 22532857 DOI: 10.1371/journal.pone.0035508 |
0.347 |
|
| 2012 |
Turban S, Stretton C, Drouin O, Green CJ, Watson ML, Gray A, Ross F, Lantier L, Viollet B, Hardie DG, Marette A, Hundal HS. Defining the contribution of AMP-activated protein kinase (AMPK) and protein kinase C (PKC) in regulation of glucose uptake by metformin in skeletal muscle cells. The Journal of Biological Chemistry. 287: 20088-99. PMID 22511782 DOI: 10.1074/jbc.M111.330746 |
0.389 |
|
| 2012 |
Wang P, Zhang RY, Song J, Guan YF, Xu TY, Du H, Viollet B, Miao CY. Loss of AMP-activated protein kinase-α2 impairs the insulin-sensitizing effect of calorie restriction in skeletal muscle. Diabetes. 61: 1051-61. PMID 22396207 DOI: 10.2337/db11-1180 |
0.387 |
|
| 2011 |
Miller RA, Chu Q, Le Lay J, Scherer PE, Ahima RS, Kaestner KH, Foretz M, Viollet B, Birnbaum MJ. Adiponectin suppresses gluconeogenic gene expression in mouse hepatocytes independent of LKB1-AMPK signaling. The Journal of Clinical Investigation. 121: 2518-28. PMID 21606593 DOI: 10.1172/Jci45942 |
0.374 |
|
| 2011 |
Xu MJ, Song P, Shirwany N, Liang B, Xing J, Viollet B, Wang X, Zhu Y, Zou MH. Impaired expression of uncoupling protein 2 causes defective postischemic angiogenesis in mice deficient in AMP-activated protein kinase α subunits. Arteriosclerosis, Thrombosis, and Vascular Biology. 31: 1757-65. PMID 21597006 DOI: 10.1161/ATVBAHA.111.227991 |
0.319 |
|
| 2011 |
Bauwens JD, Schmuck EG, Lindholm CR, Ertel RL, Mulligan JD, Hovis I, Viollet B, Saupe KW. Cold tolerance, cold-induced hyperphagia, and nonshivering thermogenesis are normal in αâ‚-AMPK-/- mice. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. 301: R473-83. PMID 21593427 DOI: 10.1152/Ajpregu.00444.2010 |
0.312 |
|
| 2011 |
Um JH, Pendergast JS, Springer DA, Foretz M, Viollet B, Brown A, Kim MK, Yamazaki S, Chung JH. AMPK regulates circadian rhythms in a tissue- and isoform-specific manner. Plos One. 6: e18450. PMID 21483791 DOI: 10.1371/Journal.Pone.0018450 |
0.306 |
|
| 2011 |
Wang S, Liang B, Viollet B, Zou MH. Inhibition of the AMP-activated protein kinase-α2 accentuates agonist-induced vascular smooth muscle contraction and high blood pressure in mice. Hypertension. 57: 1010-7. PMID 21464390 DOI: 10.1161/HYPERTENSIONAHA.110.168906 |
0.331 |
|
| 2011 |
Zelenak C, Föller M, Velic A, Krug K, Qadri SM, Viollet B, Lang F, MacEk B. Proteome analysis of erythrocytes lacking AMP-activated protein kinase reveals a role of PAK2 kinase in eryptosis Journal of Proteome Research. 10: 1690-1697. PMID 21214270 DOI: 10.1021/Pr101004J |
0.356 |
|
| 2010 |
Jelenik T, Rossmeisl M, Kuda O, Jilkova ZM, Medrikova D, Kus V, Hensler M, Janovska P, Miksik I, Baranowski M, Gorski J, Hébrard S, Jensen TE, Flachs P, Hawley S, ... Viollet B, et al. AMP-activated protein kinase α2 subunit is required for the preservation of hepatic insulin sensitivity by n-3 polyunsaturated fatty acids. Diabetes. 59: 2737-46. PMID 20693347 DOI: 10.2337/db09-1716 |
0.305 |
|
| 2010 |
Beall C, Piipari K, Al-Qassab H, Smith MA, Parker N, Carling D, Viollet B, Withers DJ, Ashford ML. Loss of AMP-activated protein kinase alpha2 subunit in mouse beta-cells impairs glucose-stimulated insulin secretion and inhibits their sensitivity to hypoglycaemia. The Biochemical Journal. 429: 323-33. PMID 20465544 DOI: 10.1042/Bj20100231 |
0.371 |
|
| 2010 |
Lantier L, Mounier R, Leclerc J, Pende M, Foretz M, Viollet B. Coordinated maintenance of muscle cell size control by AMP-activated protein kinase. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 24: 3555-61. PMID 20460585 DOI: 10.1096/Fj.10-155994 |
0.324 |
|
| 2010 |
Um JH, Park SJ, Kang H, Yang S, Foretz M, McBurney MW, Kim MK, Viollet B, Chung JH. AMP-activated protein kinase-deficient mice are resistant to the metabolic effects of resveratrol. Diabetes. 59: 554-63. PMID 19934007 DOI: 10.2337/Db09-0482 |
0.405 |
|
| 2009 |
Williams T, Forsberg LJ, Viollet B, Brenman JE. Basal autophagy induction without AMP-activated protein kinase under low glucose conditions. Autophagy. 5: 1155-65. PMID 19844161 DOI: 10.4161/Auto.5.8.10090 |
0.338 |
|
| 2009 |
Mounier R, Lantier L, Leclerc J, Sotiropoulos A, Pende M, Daegelen D, Sakamoto K, Foretz M, Viollet B. Important role for AMPKalpha1 in limiting skeletal muscle cell hypertrophy. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 23: 2264-73. PMID 19237506 DOI: 10.1096/Fj.08-119057 |
0.316 |
|
| 2009 |
Guigas B, Sakamoto K, Taleux N, Reyna SM, Musi N, Viollet B, Hue L. Beyond AICA riboside: in search of new specific AMP-activated protein kinase activators. Iubmb Life. 61: 18-26. PMID 18798311 DOI: 10.1002/iub.135 |
0.319 |
|
| 2009 |
Kongsuphol P, Hieke B, Ousingsawat J, Almaca J, Viollet B, Schreiber R, Kunzelmann K. Regulation of Cl(-) secretion by AMPK in vivo. PflüGers Archiv : European Journal of Physiology. 457: 1071-8. PMID 18752001 DOI: 10.1007/s00424-008-0577-3 |
0.316 |
|
| 2008 |
Habets DD, Coumans WA, El Hasnaoui M, Zarrinpashneh E, Bertrand L, Viollet B, Kiens B, Jensen TE, Richter EA, Bonen A, Glatz JF, Luiken JJ. Crucial role for LKB1 to AMPKalpha2 axis in the regulation of CD36-mediated long-chain fatty acid uptake into cardiomyocytes. Biochimica Et Biophysica Acta. 1791: 212-9. PMID 19159696 DOI: 10.1016/j.bbalip.2008.12.009 |
0.344 |
|
| 2008 |
Jensen TE, Schjerling P, Viollet B, Wojtaszewski JF, Richter EA. AMPK alpha1 activation is required for stimulation of glucose uptake by twitch contraction, but not by H2O2, in mouse skeletal muscle. Plos One. 3: e2102. PMID 18461163 DOI: 10.1371/journal.pone.0002102 |
0.306 |
|
| 2008 |
Deshmukh AS, Treebak JT, Long YC, Viollet B, Wojtaszewski JF, Zierath JR. Role of adenosine 5'-monophosphate-activated protein kinase subunits in skeletal muscle mammalian target of rapamycin signaling. Molecular Endocrinology (Baltimore, Md.). 22: 1105-12. PMID 18276828 DOI: 10.1210/me.2007-0448 |
0.39 |
|
| 2007 |
Klein DK, Pilegaard H, Treebak JT, Jensen TE, Viollet B, Schjerling P, Wojtaszewski JF. Lack of AMPKalpha2 enhances pyruvate dehydrogenase activity during exercise. American Journal of Physiology. Endocrinology and Metabolism. 293: E1242-9. PMID 17711995 DOI: 10.1152/ajpendo.00382.2007 |
0.31 |
|
| 2007 |
Claret M, Smith MA, Batterham RL, Selman C, Choudhury AI, Fryer LG, Clements M, Al-Qassab H, Heffron H, Xu AW, Speakman JR, Barsh GS, Viollet B, Vaulont S, Ashford ML, et al. AMPK is essential for energy homeostasis regulation and glucose sensing by POMC and AgRP neurons. The Journal of Clinical Investigation. 117: 2325-36. PMID 17671657 DOI: 10.1172/Jci31516 |
0.315 |
|
| 2007 |
Aguilar V, Alliouachene S, Sotiropoulos A, Sobering A, Athea Y, Djouadi F, Miraux S, Thiaudière E, Foretz M, Viollet B, Diolez P, Bastin J, Benit P, Rustin P, Carling D, et al. S6 kinase deletion suppresses muscle growth adaptations to nutrient availability by activating AMP kinase. Cell Metabolism. 5: 476-87. PMID 17550782 DOI: 10.1016/J.Cmet.2007.05.006 |
0.362 |
|
| 2007 |
Um JH, Yang S, Yamazaki S, Kang H, Viollet B, Foretz M, Chung JH. Activation of 5'-AMP-activated kinase with diabetes drug metformin induces casein kinase Iepsilon (CKIepsilon)-dependent degradation of clock protein mPer2. The Journal of Biological Chemistry. 282: 20794-8. PMID 17525164 DOI: 10.1074/Jbc.C700070200 |
0.327 |
|
| 2007 |
Goirand F, Solar M, Athea Y, Viollet B, Mateo P, Fortin D, Leclerc J, Hoerter J, Ventura-Clapier R, Garnier A. Activation of AMP kinase alpha1 subunit induces aortic vasorelaxation in mice. The Journal of Physiology. 581: 1163-71. PMID 17446219 DOI: 10.1113/jphysiol.2007.132589 |
0.315 |
|
| 2007 |
Lee MJ, Feliers D, Mariappan MM, Sataranatarajan K, Mahimainathan L, Musi N, Foretz M, Viollet B, Weinberg JM, Choudhury GG, Kasinath BS. A role for AMP-activated protein kinase in diabetes-induced renal hypertrophy American Journal of Physiology - Renal Physiology. 292: F617-F627. PMID 17018841 DOI: 10.1152/ajprenal.00278.2006 |
0.332 |
|
| 2006 |
Rencurel F, Foretz M, Kaufmann MR, Stroka D, Looser R, Leclerc I, da Silva Xavier G, Rutter GA, Viollet B, Meyer UA. Stimulation of AMP-activated protein kinase is essential for the induction of drug metabolizing enzymes by phenobarbital in human and mouse liver. Molecular Pharmacology. 70: 1925-34. PMID 16988011 DOI: 10.1124/mol.106.029421 |
0.319 |
|
| 2006 |
Brauner P, Kopecky P, Flachs P, Kuda O, Vorlicek J, Planickova L, Vitkova I, Andreelli F, Foretz M, Viollet B, Kopecky J. Expression of uncoupling protein 3 and GLUT4 gene in skeletal muscle of preterm newborns: possible control by AMP-activated protein kinase. Pediatric Research. 60: 569-75. PMID 16966355 DOI: 10.1203/01.PDR.0000242301.64555.e2 |
0.305 |
|
| 2006 |
Treebak JT, Glund S, Deshmukh A, Klein DK, Long YC, Jensen TE, Jørgensen SB, Viollet B, Andersson L, Neumann D, Wallimann T, Richter EA, Chibalin AV, Zierath JR, Wojtaszewski JF. AMPK-mediated AS160 phosphorylation in skeletal muscle is dependent on AMPK catalytic and regulatory subunits. Diabetes. 55: 2051-8. PMID 16804075 DOI: 10.2337/Db06-0175 |
0.396 |
|
| 2006 |
Andreelli F, Foretz M, Knauf C, Cani PD, Perrin C, Iglesias MA, Pillot B, Bado A, Tronche F, Mithieux G, Vaulont S, Burcelin R, Viollet B. Liver adenosine monophosphate-activated kinase-alpha2 catalytic subunit is a key target for the control of hepatic glucose production by adiponectin and leptin but not insulin. Endocrinology. 147: 2432-41. PMID 16455782 DOI: 10.1210/en.2005-0898 |
0.406 |
|
| 2005 |
Foretz M, Ancellin N, Andreelli F, Saintillan Y, Grondin P, Kahn A, Thorens B, Vaulont S, Viollet B. Short-term overexpression of a constitutively active form of AMP-activated protein kinase in the liver leads to mild hypoglycemia and fatty liver. Diabetes. 54: 1331-9. PMID 15855317 DOI: 10.2337/diabetes.54.5.1331 |
0.574 |
|
| 2004 |
Jørgensen SB, Nielsen JN, Birk JB, Olsen GS, Viollet B, Andreelli F, Schjerling P, Vaulont S, Hardie DG, Hansen BF, Richter EA, Wojtaszewski JFP. The α2-5′ AMP-activated protein kinase is a site 2 glycogen synthase kinase in skeletal muscle and is responsive to glucose loading Diabetes. 53: 3074-3081. PMID 15561936 DOI: 10.2337/diabetes.53.12.3074 |
0.355 |
|
| 2004 |
Villena JA, Viollet B, Andreelli F, Kahn A, Vaulont S, Sul HS. Induced adiposity and adipocyte hypertrophy in mice lacking the AMP-activated protein kinase-alpha2 subunit. Diabetes. 53: 2242-9. PMID 15331533 DOI: 10.2337/Diabetes.53.9.2242 |
0.602 |
|
| 2003 |
Viollet B, Andreelli F, Jørgensen SB, Perrin C, Geloen A, Flamez D, Mu J, Lenzner C, Baud O, Bennoun M, Gomas E, Nicolas G, Wojtaszewski JF, Kahn A, Carling D, et al. The AMP-activated protein kinase alpha2 catalytic subunit controls whole-body insulin sensitivity. The Journal of Clinical Investigation. 111: 91-8. PMID 12511592 DOI: 10.1172/Jci16567 |
0.604 |
|
| Show low-probability matches. |